Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for “Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection”

Life Science

Joinn Labs to Acquire US-Based Biomere, a Pre-clinical CRO, for $27.3 Million

Life Science

Tencent Miying Launches AI-supported Auxiliary Diagnostic System

Life Science

WuXi Biologics Signs LOI for $3 Billion Vaccine Manufacturing Contract

Life Science

Mabpharm Hong Kong IPO to Raise $172 Million at $900 Million Valuation

Life Science

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

Life Science

MGI Tech, a BGI Subsidiary that Makes Gene Sequencers, Raises $200 Million

Life Science

Viva Biotech Completes $194 Million Hong Kong IPO; Trades Higher

Life Science

China to bid on D.C. Metro rail deal as national security hawks circle

Technology

Takeda Divests Eye Drug to Novartis for $5.3 Billion

Life Science

InnoCare Planning $250 Million IPO on Hong Kong Exchange

Life Science

Volkswagen teams up with China’s NIU to make e-scooters: Die Welt

Technology

Suzhou’s Tot Biopharm, a Cancer Company, Plans Hong Kong IPO

Life Science

CStone Acquires China Rights to Tri-Specific Cancer Immunotherapy from Numab

Life Science

Ascletis and 3-V Bio Start US-China Trial of NASH Candidate

Life Science